Skip to content
Screener

LivaNova LIVN Interest Income

Interest Income at other companies

Abbott logo
AbbottABT
$52M-26.8%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
$523K-27.2%
Inspire Medical Systems logo
Inspire Medical SystemsINSP
$3.74M-26.2%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$3.9M+2.9%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$3.39M+13.6%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$351K+132%

Other financials

Income statement

See full
Revenue$390.6M+10.8%
Gross profit$273.7M+14.5%
Operating income$49.5M-8.7%
Net income$108.6M+300%
EPS (diluted)$1.93+286%

Balance sheet

See full
Cash & equivalents$516.6M-13.0%
Total debt$348.5M-27.8%
Total equity$1.3B+18.0%
Total assets$2.6B+5.4%

Cash flow

See full
Operating cash flow$66.6M+5.8%
CapEx$31.6M+108%
Free cash flow$35.0M-26.7%

Valuation

See full
Market cap$4.21B+55.7%
Enterprise value$4.05B+55.9%
P/E22.8×-68.5×
P/S2.9×+0.8×

Profitability

See full
Gross margin68.1%+0.1pp
Operating margin12.7%-0.7pp
Net margin-16.1%-18.0pp
FCF margin10.1%-2.3pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.2×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The source filing: LivaNova’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 2:23 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001639691-26-000090
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Fair value adjustment - 2029 Embedded Derivative (1)$(59,650)$(10,867)$(69,000)$3,726
Fair value adjustment - 2029 Capped Calls (1)19,0164,46820,742(2,077)
Gain on sale of investment (2)13,64813,648
Interest income3,8314,1837,38310,626
FX fluctuations(779)(1,240)(1,368)(1,850)
Impairment of investment(1,132)
Investment revaluation - Ceribell, Inc. (3)(1,008)(3,622)
Fair value adjustment - 2025 Embedded Derivative (1)(489)1,552

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is LivaNova's interest income?
LivaNova (LIVN) reported interest income of $3.83M in Q2 2026.
How has LivaNova's interest income changed year-over-year?
LivaNova's interest income decreased by 8.4% year-over-year, from $4.18M to $3.83M.
What is the long-term trend for LivaNova's interest income?
Over 4 years (2021 to 2025), LivaNova's interest income has grown at a 147.1% compound annual growth rate (CAGR), from $509K to $18.98M.
What does interest income mean?
Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.

Ask your AI about LivaNova's interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude